Company: NIVFW
Filing Date: 2025-09-15
Form Type: F-1
Source: 0001213900-25-087717
Chunk: 176

Company: NewGenIvf Group Ltd
Filing Date: 2025-09-15
Form: F-1
Chunk 176
---
 in this prospectus concerning the contents of any contract, agreement or other document are summaries of all material information about the documents summarized, but are not complete descriptions of all terms of these documents. If we filed any of these documents as an exhibit to the Registration Statement, you may read the document itself for a complete description of its terms. We are subject to the periodic reporting and other information requirements of the Exchange Act as applicable to a “Foreign Private Issuer,” and we will file annual reports and other information from time to time with the SEC in accordance with such requirements. Our filings with the SEC are also available to the public through the SEC’s website at www.sec.gov. As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we will not be required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. We maintain a corporate website at www.newgenivf.com. Information contained on, or that can be accessed through, our website does not constitute a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference. We will post on our website any materials required to be so posted on such website under applicable corporate or securities laws and regulations, including, posting any XBRL interactive financial data required to be filed with the SEC and any notices of general meetings of our shareholders. 108 50,000,000 Ordinary Shares NewGenIvf Group Limited PROSPECTUS , 2025 NEWGENIVF LIMITED

| AUDITED CONSOLIDATED FINANCIAL STATEMENTS                                                                                  |     |     |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 1171)                                                   |     | F-2 |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: 6743)                                                   |     | F-4 |
| Consolidated Balance Sheets as of December 31, 2024 and 2023                                                               |     | F-5 |
| Consolidated Statements of Operations and Comprehensive Income (Loss) for the Years Ended December 31, 2024, 2023 and 2022 |     | F-6 |
| Consolidated Statements of Changes in Share